丙型肝炎病毒与先天性和适应性免疫反应：共同进化与共存的故事
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.
作者信息
Rehermann Barbara
机构信息
Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH/DHHS, Bethesda, MD 20892, USA.
出版信息
J Clin Invest. 2009 Jul;119(7):1745-54. doi: 10.1172/JCI39133. Epub 2009 Jul 1.
Abstract
Since the identification of the hepatitis C virus (HCV) 20 years ago, much progress has been made in our understanding of its life cycle and interaction with the host immune system. Much has been learned from HCV itself, which, via decades of coevolution, gained an intricate knowledge of host innate and adaptive immune responses and developed sophisticated ways to preempt, subvert, and antagonize them. This review discusses the clinical, virological, and immunological features of acute and chronic hepatitis C and the role of the immune response in spontaneous and treatment-induced HCV clearance.
摘要
自20年前丙型肝炎病毒（HCV）被发现以来，我们对其生命周期以及与宿主免疫系统相互作用的理解取得了很大进展。从HCV自身我们了解到很多情况，经过数十年的共同进化，它对宿主的固有免疫和适应性免疫反应有了深入认识，并形成了先发制人、颠覆和对抗这些反应的复杂方式。本文综述了急性和慢性丙型肝炎的临床、病毒学和免疫学特征，以及免疫反应在自发清除和治疗诱导清除HCV中的作用。
相似文献
1
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.
J Clin Invest. 2009 Jul;119(7):1745-54. doi: 10.1172/JCI39133. Epub 2009 Jul 1.
2
A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
Antiviral Res. 2006 Mar;69(3):129-41. doi: 10.1016/j.antiviral.2005.12.001. Epub 2006 Jan 4.
3
Emerging concepts in immunity to hepatitis C virus infection.
J Clin Invest. 2013 Oct;123(10):4121-30. doi: 10.1172/JCI67714. Epub 2013 Oct 1.
4
Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.
Intern Med. 2006;45(4):183-91. doi: 10.2169/internalmedicine.45.1530. Epub 2006 Mar 15.
5
Host-virus interactions in hepatitis B and hepatitis C infection.
J Gastroenterol. 2016 May;51(5):409-20. doi: 10.1007/s00535-016-1183-3. Epub 2016 Feb 19.
6
Organ system view of the hepatic innate immunity in HCV infection.
J Med Virol. 2016 Dec;88(12):2025-2037. doi: 10.1002/jmv.24569. Epub 2016 May 13.
7
Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
Cells. 2019 Apr 25;8(4):376. doi: 10.3390/cells8040376.
8
Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Biol Chem. 2008 Oct;389(10):1283-98. doi: 10.1515/BC.2008.147.
9
[Adaptive cell immune response against the hepatitis C virus infection].
Med Clin (Barc). 2007 Oct 6;129(12):469-76. doi: 10.1157/13111005.
10
Innate and Adaptive Immune Responses in Chronic HCV Infection.
Curr Drug Targets. 2017;18(7):826-843. doi: 10.2174/1389450116666150825110532.
引用本文的文献
1
Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response.
Clin Exp Med. 2025 Jul 30;25(1):269. doi: 10.1007/s10238-025-01811-y.
2
Immunogenicity of an Intranasal Dual (Core and Surface)-Antigen Vaccine Against Hepatitis B Virus Enhanced by Carboxyl-Vinyl Polymer Excipients.
Vaccines (Basel). 2025 Apr 25;13(5):464. doi: 10.3390/vaccines13050464.
3
Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals.
Microorganisms. 2024 Sep 22;12(9):1926. doi: 10.3390/microorganisms12091926.
4
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations.
Clin Transl Med. 2024 Aug;14(8):e1812. doi: 10.1002/ctm2.1812.
5
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C.
Clin Exp Med. 2024 Aug 8;24(1):184. doi: 10.1007/s10238-024-01432-x.
6
Properties and Mechanisms of Deletions, Insertions, and Substitutions in the Evolutionary History of SARS-CoV-2.
Int J Mol Sci. 2024 Mar 26;25(7):3696. doi: 10.3390/ijms25073696.
7
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.
Hepatology. 2024 Jul 1;80(1):202-222. doi: 10.1097/HEP.0000000000000804. Epub 2024 Feb 20.
8
Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection.
BMC Infect Dis. 2024 Jan 25;24(1):134. doi: 10.1186/s12879-024-09032-6.
9
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.
Immunity. 2024 Jan 9;57(1):40-51.e5. doi: 10.1016/j.immuni.2023.12.004. Epub 2024 Jan 2.
10
Cellular, Molecular, Pharmacological, and Nano-Formulation Aspects of Thymoquinone-A Potent Natural Antiviral Agent.
Molecules. 2023 Jul 16;28(14):5435. doi: 10.3390/molecules28145435.
本文引用的文献
1
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
Gastroenterology. 2009 Jun;136(7):2377-86. doi: 10.1053/j.gastro.2009.02.080. Epub 2009 Mar 17.
2
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
PLoS Pathog. 2009 Feb;5(2):e1000313. doi: 10.1371/journal.ppat.1000313. Epub 2009 Feb 27.
3
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
J Clin Invest. 2009 Mar;119(3):551-64. doi: 10.1172/JCI36604. Epub 2009 Feb 23.
4
Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model.
Gastroenterology. 2009 Apr;136(4):1391-401. doi: 10.1053/j.gastro.2008.12.034. Epub 2008 Dec 13.
5
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.
6
Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes.
PLoS Pathog. 2009 Jan;5(1):e1000269. doi: 10.1371/journal.ppat.1000269. Epub 2009 Jan 16.
7
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
J Clin Invest. 2009 Feb;119(2):376-86. doi: 10.1172/JCI36587. Epub 2009 Jan 12.
8
Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.
Hepatology. 2009 Jan;49(1):12-21. doi: 10.1002/hep.22624.
9
Toll-like receptor and RIG-I-like receptor signaling.
Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020.
10
Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
J Virol. 2009 Feb;83(4):2011-4. doi: 10.1128/JVI.01888-08. Epub 2008 Dec 3.
Zotero 插件